Senior Biostatistician - Oncology (FSP -Permanent Homebased)

We are seeking an experienced and proactive Senior Biostatistician to join our FSP team, supporting a global pharmaceutical client. This is a permanent, home-based position offering the opportunity to work on late-phase global oncology trials, with a focus on hematology and regulatory submissions.

Key Responsibilities

• Serve as the lead statistician on global late-phase registration trials, particularly in oncology (hematology preferred).
• Independently contribute to study design, statistical analysis plans (SAPs), and regulatory submission strategies.
• Participate in study team meetings, providing statistical guidance and collaborating with cross-functional teams.
• Address health authority questions and support responses with appropriate statistical analyses and documentation.
• Perform hands-on statistical programming to derive outputs and summary statistics using ADaM and SDTM datasets.
• Ensure timely and accurate delivery of statistical deliverables in compliance with regulatory standards.

Required Qualifications

• Advanced degree (Master's or PhD) in Biostatistics, Statistics, or a related field.
• 5+ years of experience in clinical trials, with a strong focus on oncology (hematology and late-phase preferred).
• Proven experience working on registrational studies and regulatory submissions.
• Strong knowledge of CDISC standards, particularly ADaM and SDTM.
• Proficiency in SAS programming and ability to perform hands-on statistical analyses.
• Excellent communication skills and ability to work independently in a global, cross-functional environment.

Preferred Experience

• Prior involvement in FDA/EMA submissions.
• Experience addressing regulatory agency queries.
• Familiarity with real-world evidence and observational studies is a plus.

Why Join Us?

• Work on high-impact global studies with a focus on improving cancer treatment outcomes.
• Be part of a collaborative and innovative team environment.
• Enjoy the flexibility of remote work with a permanent contract.
• Gain exposure to regulatory strategy and cutting-edge oncology research.